Sign up to save your podcasts
Or
Share Episode 29 - Adrian Rawcliffe, CEO of Adaptimmune
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 29 - Adrian Rawcliffe, CEO of Adaptimmune
Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
I’m pleased to introduce Adrian Rawcliffe, CEO of Adaptimmune Therapeutics. With over 20 years of experience in the pharmaceutical and biotech industries, Adrian has led pivotal roles at GSK and now spearheads the development of breakthrough T-cell therapies at Adaptimmune, tackling some of the toughest challenges in cancer and beyond.
We’re excited to dive into Adrian’s journey, the advancements at Adaptimmune, and what the future holds for T-cell therapies. Welcome to the show, Adrian!
Enjoy and stay tuned.
View all episodes
By Max Brennan - Biotech HeadHunterWelcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
I’m pleased to introduce Adrian Rawcliffe, CEO of Adaptimmune Therapeutics. With over 20 years of experience in the pharmaceutical and biotech industries, Adrian has led pivotal roles at GSK and now spearheads the development of breakthrough T-cell therapies at Adaptimmune, tackling some of the toughest challenges in cancer and beyond.
We’re excited to dive into Adrian’s journey, the advancements at Adaptimmune, and what the future holds for T-cell therapies. Welcome to the show, Adrian!
Enjoy and stay tuned.